About Advanced Chemotherapy Technologies
Advanced Chemotherapy Technologies is a company based in Raleigh (United States) founded in 2014. Advanced Chemotherapy Technologies has raised $8 million across 3 funding rounds from investors including Khosla Ventures, National Cancer Institute and Spectrum. Advanced Chemotherapy Technologies operates in a competitive market with competitors including TriSalus Life Sciences, Cooler Heads, Luminate Medical, Cognos Therapeutics and Delcath, among others.
- Headquarter Raleigh, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Khosla Ventures
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Advanced Chemotherapy Technologies
Unlock access to complete
Unlock access to complete
Scientific Team
4 people
Founder Team
2 people
CTO Team
1 people
Leadership Team
1 people
Board Team
1 people
Unlock access to complete
Funding Insights of Advanced Chemotherapy Technologies
Advanced Chemotherapy Technologies has successfully raised a total of $8M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Advanced Chemotherapy Technologies
Advanced Chemotherapy Technologies has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Khosla Ventures, National Cancer Institute and Spectrum.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
Cancer research is conducted and supported by the institute.
|
Locked | Locked | Locked | |
|
Spectrum is engaged in providing financial and accounting services.
|
Locked | Locked | Locked |
Investor details for Advanced Chemotherapy Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Advanced Chemotherapy Technologies
Investment portfolio details for Advanced Chemotherapy Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Advanced Chemotherapy Technologies
Detailed financials for Advanced Chemotherapy Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Advanced Chemotherapy Technologies Comparisons
Peer comparison for Advanced Chemotherapy Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Advanced Chemotherapy Technologies
Advanced Chemotherapy Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TriSalus Life Sciences, Cooler Heads, Luminate Medical, Cognos Therapeutics and Delcath, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of drug delivery devices to treat cancers
|
|
| Locked | Locked | Locked |
Developer of cold cap system to prevent chemotherapy side effects
|
|
| Locked | Locked | Locked |
Developer of a medical device to prevent hair loss during chemotherapy
|
|
| Locked | Locked | Locked |
Cognos Therapeutics is focused on innovative neurological and oncological treatments.
|
|
| Locked | Locked | Locked |
Delcath Systems, Inc. is focused on liver cancer treatments.
|
Detailed competitors of Advanced Chemotherapy Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Advanced Chemotherapy Technologies
Complete news archive for Advanced Chemotherapy Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Advanced Chemotherapy Technologies
Advanced Chemotherapy Technologies was founded in 2014 and raised its 1st funding round 6 years after it was founded.
Advanced Chemotherapy Technologies is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Advanced Chemotherapy Technologies is a funded company, having raised a total of $8M across 3 funding rounds to date.
Advanced Chemotherapy Technologies was founded in 2014 and is headquartered in Raleigh, United States. The company operates in the medical device sector, focusing on oncology treatments. A device is developed that employs reversible electroporation to temporarily open blood vessels, enabling chemotherapy drugs to penetrate tumors more effectively. This process supports tumor shrinkage, facilitating potential surgical removal. Operations center on device innovation for improved cancer therapy delivery.
Advanced Chemotherapy Technologies's top competitors include TriSalus Life Sciences, Cooler Heads and Cognos Therapeutics.
Advanced Chemotherapy Technologies has 3 investors. Key investors include Khosla Ventures, National Cancer Institute, and Spectrum.